Vertex Pharmaceuticals Incorporated
Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2
Last updated:
Abstract:
The present invention provides crystalline forms of a compound of formula (I): ##STR00001## Also provided are pharmaceutical compositions that include the provided crystalline forms and methods of using the provided crystalline forms and pharmaceutical compositions for the treatment of cancer.
Status:
Grant
Type:
Utility
Filling date:
20 Dec 2018
Issue date:
11 Aug 2020